肝细胞癌肿瘤微环境中肿瘤浸润淋巴细胞的研究进展

Research progress of tumor infiltrating lymphocytes in the tumor microenvironment of hepatocellular carcinoma

肝癌是病死率极高的恶性肿瘤。随着靶向药物、免疫治疗等技术手段的不断发展,转化治疗已成为目前中晚期肝癌治疗的共识。肝脏自身存在的免疫耐受,肿瘤组织以及各种免疫成分构成了动态变化的肝癌微环境。肝癌微环境下的免疫逃逸是当前免疫治疗的主要障碍。细胞免疫是机体抗肿瘤免疫的重要组成部分,免疫细胞的状态和功能与癌症预后密切相关。本文归纳了肝细胞癌微环境中肿瘤浸润淋巴细胞的研究进展,以便更好地探索针对性的抗肿瘤临床治疗策略。

Liver cancer is a malignant tumor with a high mortality rate.With the continuous development of targeted drugs,immunotherapy and other technological means,translational therapy has become a consensus in the treatment of advanced liver cancer.The liver's inherent immune tolerance,tumor tissue,and various immune components constitute a dynamically changing liver cancer microenvironment.The immune escape in the microenvironment of liver cancer is the main obstacle to current immunotherapy.Cellular immunity is an important component of anti-tumor immunity,and the status and function of immune cells are closely related to cancer prognosis.This article reviews the progress of tumor infiltrating lymphocytes in the tumor microenvironment of hepatocellular carcinoma,in order to benefit the exploring of targeted antitumor therapy.